Key result
Aortic valve replacement with a bioprosthesis was required in a 69-year-old patient with infective endocarditis, highlighting the risk of recurrence in patients with bioprosthetic heart valves.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
This case highlights the complications of infective endocarditis and its tendency to recur in patients with bioprosthetic heart valves.
Infective endocarditis (IE) is an infection that does not usually respond rapidly to treatment, often because its early symptoms are non-specific. The diseased valves (native or bioprosthetic) may be calcified and the thrombotic vegetations on them typically friable and embolize easily. Left untreated IE leads to damage to the infected valve and to congestive heart failure (CHF). Its treatment usually requires heart valve replacement. Our 69-year-old patient had IE, and underwent aortic valve replacement (AVR) with a bioprosthesis. This case stresses the complications of IE and its tendency to recur in patients with bioprosthetic heart valves (BHV) who previously had IE.
No takes yet. Share an insight, caveat, or question.
McIntyre et al. (2017) conducted a case report in Infective endocarditis (n=1). Aortic valve replacement with a bioprosthesis was evaluated. Aortic valve replacement with a bioprosthesis was required in a 69-year-old patient with infective endocarditis, highlighting the risk of recurrence in patients with bioprosthetic heart valves.
Synapse has enriched 10 related papers. Consider them for comparative context: